The synthesis of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, involves a complex several-stage chemical process. Early routes focused on peptide fragment coupling, utilizing solid-phase creation more info methodologies to build the long protein sequence. Subsequent investigation has explored various approaches, includin